Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02532244 · ClinicalTrials.gov registry record
Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
A clinical trial of Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- 230
- Enrollment target
- 3
- Study locations
NCT02532244 is a study of Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy that has completed, run by Nemours Children's Clinic. The registered enrollment target is 230 participants, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (74% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT02532244, a study of Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this study is to establish a genetic registry of patients with early-onset motor neuron and neuromuscular diseases. The investigators will collect samples from patients with a motor neuron or a neuromuscular disorder and their family members. The samples to be collected will be obtained using minimally invasive (whole blood) means. The research team will then extract high quality genomic DNA or RNA from these samples and use it to identify and confirm novel gene mutations and to identify genes which regulate the severity of motor neuron/neuromuscular diseases.
Conditions Studied
Interventions
- OTHER sample collection
Study Locations (3)
Florida
- Nemours Children's Specialty Care - Jacksonville
- Nemours Children's Hospital Orlando - Orlando
Delaware
- Nemours Children's Hospital Delaware - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2015-06 |
| Est. Completion | 2024-12-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02532244
The ClinicalTrials.gov registry entry for NCT02532244 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 230 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (74% lower). The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which sample collection is the first listed.
NCT02532244 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Florida, Delaware.
Frequently Asked Questions
What is clinical trial NCT02532244 about?
NCT02532244 is a clinical study titled "Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases". The goal of this study is to establish a genetic registry of patients with early-onset motor neuron and neuromuscular diseases. The investigators will collect samples from patients with a motor neuron or a neuromuscular disorder and their family members. The samples to be collected will be obtained ...
What is the current status of trial NCT02532244?
This trial is currently completed. The enrollment target is 230 participants. The study started on 2015-06. Estimated completion is 2024-12-18.
What conditions does trial NCT02532244 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Motor Neuron Disease, Muscular Dystrophy, Charcot Marie Tooth Disease.
What interventions are being tested in trial NCT02532244?
The interventions under investigation include: sample collection (OTHER).
Who is sponsoring clinical trial NCT02532244?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02532244 being conducted?
This trial has 3 study locations across Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
PREVENT ALL ALS Study
RECRUITING
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.